Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
Open Access
- 1 June 2023
- journal article
- review article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 37 (11-12) , e24941
Abstract
During 2019, the SARS‐CoV‐2 emerged from China, and during months, COVID‐19 spread in many countries around the world. The expanding data about pathogenesis of this virus could elucidate the exact mechanism by which COVID‐19 caused death in humans. One of the pathogenic mechanisms of this disease is coagulation. Coagulation disorders that affect both venous and arterial systems occur in patients with COVID‐19. The possible mechanism involved in the coagulation could be excessive inflammation induced by SARS‐CoV‐2. However, it is not yet clear well how SARS‐CoV‐2 promotes coagulopathy. However, some factors, such as pulmonary endothelial cell damage and some anticoagulant system disorders, are assumed to have an important role. In this study, we assessed conducted studies about COVID‐19‐induced coagulopathy to obtain clearer vision of the wide range of manifestations and possible pathogenesis mechanisms.Keywords
This publication has 225 references indexed in Scilit:
- The Vascular Endothelium and Human DiseasesInternational Journal of Biological Sciences, 2013
- Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot FormationPLOS ONE, 2012
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate ProteoglycansPLOS ONE, 2011
- Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartanAmerican Journal of Physiology-Renal Physiology, 2009
- Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolismAmerican Journal of Hematology, 2007
- Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2PLOS ONE, 2007
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- The clinical pathology of severe acute respiratory syndrome (SARS): a report from ChinaThe Journal of Pathology, 2003
- Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysisBMJ, 2003
- Review: Infectious Diseases and Coagulation DisordersThe Journal of Infectious Diseases, 1999